Osteoanabolics Versus Antiresorptives: Which First?

J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz238. doi: 10.1210/clinem/dgz238.

Authors

Cristiana Cipriani¹, John P Bilezikian²

Affiliations

¹ Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.
² Metabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.

PMID: 31782489
DOI: 10.1210/clinem/dgz238

No abstract available

Keywords: abaloparatide; alendronate; antiresorptive; fracture; osteoanabolic.

Publication types

Comment

MeSH terms

Alendronate*
Female
Humans
Osteoporosis*
Parathyroid Hormone-Related Protein
Postmenopause
Risk Reduction Behavior

Substances

Parathyroid Hormone-Related Protein
abaloparatide
Alendronate